Bain Capital Life Sciences Investors, LLC
Follow13F filer, CIK 1703031, Boston, MA
Bain Capital Life Sciences Investors, LLC reported $961,175,669 across 24 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 89.37% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011417
- Period
- 2024-09-30
- Reported value
- $961M
- Holdings
- 24
- Top 10 weight
- 89.37%
- New
- 1
- Sold out
- 2
Part of the filer group Bain Capital Life Sciences Investors, LLC
Bain Capital Credit, LPBain Capital Fund XII, LP
- Bain Capital Credit, LP
- Bain Capital Fund XII, LP
- Bain Capital Fund XI, L.P.
- Bain Capital Investors LLC
- Bain Capital Life Sciences Fund III, L.P.
- Bain Capital Life Sciences Fund II, L.P.
- Bain Capital Life Sciences Fund IV, L.P.
- Bain Capital Life Sciences III General Partner, LLC
- Bain Capital Life Sciences Investors II, LLC
- Bain Capital Life Sciences IV General Partner, LLC
- Bain Capital Life Sciences Opportunities III GP, LLC
- Bain Capital Life Sciences Opportunities III, LP
- Bain Capital Life Sciences Opportunities IV GP, LLC
- Bain Capital Life Sciences Opportunities IV, L.P.
- Bain Capital Partners XII, LLC
- Bain Capital Partners XI, L.P.
- Bain Capital Prairie Holdings (GP), LLC
- Bain Capital Prairie Holdings, LP
- Bain Capital Prairie, LLC
- Bain Capital Public Equity, LP
- Bain Capital Public Equity Management II, LLC
- Bain Capital Venture Coinvestment Fund II, L.P.
- Bain Capital Venture Coinvestment II Investors, LLC
- Bain Capital Venture Fund 2016, L.P.
- Bain Capital Venture Fund 2019, L.P.
- Bain Capital Venture Investors 2019, LLC
- BAIN CAPITAL VENTURE INVESTORS, LLC
- Bain Capital Venture Partners 2016, L.P.
- Bain Charger Holdings, L.P.
- BCPE Derby (DE) SPV (GP), LLC
- BCPE Derby (DE) SPV, LP
- BCPE Derby GP, LLC
- BCPE Derby Investor, LP
- BCPE Eagle GP, LLC
- BCPE Eagle Investor, LP
- BCPE Nucleon (DE) SPV (GP), LLC
- BCPE Nucleon (DE) SPV, LP
- BCPE Nucleon Investors (GP), LLC
- BCPE Nucleon Investors, LP
- BCPE Seminole GP III LLC
- BCPE Seminole GP II LLC
- BCPE Seminole GP LLC
- BCPE Seminole Holdings III, L.P.
- BCPE Seminole Holdings II Intermediate LP
- BCPE Seminole Holdings IV, L.P.
- BCPE Seminole Holdings LP
- BCPE Watson (DE) Aggregator GP, LLC
- BCPE Watson (DE) Aggregator, LP
- BCPE Watson (DE) BML GP, LLC
- BCPE Watson (DE) BML, LP
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CDTXnew | +703,080 | $7.56M |
| CABAadded | +1,110,924 | $5.24M |
| MARINUS PHARMACEUTICALS INCadded | +425,700 | $749K |
| XLOadded | +781,367 | $615K |
| ANNXadded | +540 | $3.2K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ARQTexited | -1,030,703 | -$9.59M |
| TNGXreduced | -180,655 | -$1.39M |
| ACRSexited | -1,000,000 | -$1.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-011417, largest first. % of portfolio is the value over $961,175,669, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NUVLNUVALENT INC | 2,697,267 | $276M | 28.71% | 0 | Timeline | ||
| NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $174M | 18.09% | 0 | Timeline | ||
| IRONDISC MEDICINE INC | 1,795,735 | $88.2M | 9.18% | 0 | Timeline | ||
| DNTHDIANTHUS THERAPEUTICS INC | 3,013,423 | $82.5M | 8.58% | 0 | Timeline | ||
| SVRASAVARA INC | 14,565,457 | $61.8M | 6.43% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 3,303,381 | $61.2M | 6.36% | 0 | Timeline | ||
| ANNXANNEXON INC | 8,449,748 | $50M | 5.2% | +540 | Timeline | ||
| SLDBSOLID BIOSCIENCES INC | 4,034,582 | $28.1M | 2.93% | 0 | Timeline | ||
| TNGXTANGO THERAPEUTICS INC | 2,712,008 | $20.9M | 2.17% | -180,655 | Timeline | ||
| KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $16.5M | 1.71% | 0 | Timeline | ||
| Mersana Therapeutics IncMersana Therapeutics Inc | 8,663,673 | $16.4M | 1.7% | 0 | |||
| CABACABALETTA BIO INC | 2,760,888 | $13M | 1.36% | +1,110,924 | Timeline | ||
| X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INC | 16,915,784 | $11.3M | 1.18% | 0 | |||
| IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $9.25M | 0.96% | 0 | Timeline | ||
| AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $8.33M | 0.87% | 0 | Timeline | ||
| CDTXCIDARA THERAPEUTICS INC | 703,080 | $7.56M | 0.79% | new | Timeline | ||
| RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $7.51M | 0.78% | 0 | Timeline | ||
| CCCCC4 THERAPEUTICS INC | 1,111,910 | $6.34M | 0.66% | 0 | Timeline | ||
| SYRSSYROS PHARMACEUTICALS INC COM | 2,750,151 | $5.91M | 0.62% | +343 | Timeline | ||
| NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.7M | 0.59% | 0 | Timeline | ||
| MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INC | 2,693,380 | $4.74M | 0.49% | +425,700 | |||
| XLOXilio Therapeutics Inc. | 4,566,817 | $3.6M | 0.37% | +781,367 | Timeline | ||
| IVVDINVIVYD INC | 1,799,595 | $1.84M | 0.19% | 0 | Timeline | ||
| NAMSWNEWAMSTERDAM PHARMA COMPANY | 100,000 | $700K | 0.07% | 0 | Timeline |
Sold out in Q3 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-011417 | base | 2024-11-14 | acceptance time not in the bulk data set |